20 years of developments in drug use among adolescents in Europe
Tendances n° 143, OFDT, 12 p.
Two major surveys, conducted every 4 years for the past 25 years in the adolescent population, allow for an international comparison of drug use: the Health Behaviour in School-Aged Children (HBSC) survey, under the auspices of the World Health Organisation (WHO), and the European School Survey Project on Alcohol and other Drugs (ESPAD), conducted with the support of the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) and CNR Institute of Clinical Physiology (IFC).
This issue of Tendances looks back at the main findings of these two surveys, with updated reports published in 2020. With a strong emphasis on mapping and infographics (some sources are available in the appendix), it offers an overview of European developments in adolescents’ initiation into and consumption of tobacco, alcohol and cannabis between the ages of 13 and 16 (including a box on other illicit drugs and the use of electronic cigarettes in 2019), over almost a quarter of a century.
Authors : Stanislas Spilka, Olivier Le Nézet, Eric Janssen, Alex Brissot, Antoine Philippon
Download the PDF file (9,38 Mo)
Drugs in Europe
The European Drug Report 2023: Trends and Developments presents the EMCDDA’s latest analysis of the drug situation in Europe. Focusing on illicit drug use, related harms and drug supply, the report contains a comprehensive set of national data across these themes and key harm-reduction interventions. This report is based on information provided to the EMCDDA by the EU Member States, the candidate country Türkiye, and Norway, in an annual reporting process.
The annual Statistical Bulletin contains the most recent available data on the drug situation in Europe provided by the Member States. These datasets underpin the analysis presented in the European Drug Report. All data may be viewed interactively on screen and downloaded in Excel format.
The European Union and the drug phenomenon
The European Union & the drug phenomenon : Frequently asked questions, joint publication between the EMCDDA and the European Commission, october 2010, 12 p.